Edesa Biotech (EDSA) logo

Edesa Biotech (EDSA) stock

Market cap $25MShares as of Aug 13

$2.59
-6.50%

As of Monday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score EDSA. It is too small and too thinly traded for a fair Quality Score.

Healthcare · Biotech

NextQ4 2027“The Company anticipates that topline data will be available fourth quarter 2027.”Trial data · SEC filing · Oct 15
Cash$10.3M, about 4 quarters at the last year's spendingOn Jun 30 · raised money since, not counted

Follow EDSA's trial news. Pro members can get an alert when Edesa Biotech files news, and see its trials, share raises, and its CEO's filings.

Get an alert when EDSA files news on its trialSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,191 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

Cash$10.3M, about 4 quarters at the last year's spendingOn Jun 30 · raised money since, not counted

What's next for EDSA, and how long its cash lasts

Next step the company has named

Q4 2027“The Company anticipates that topline data will be available fourth quarter 2027.”Trial data · SEC filing · Oct 15

What it means: the first look at a trial’s main results, as the company reports them.

A trial underway
Safety and Efficacy of EB06 Versus Placebo in Adults With Moderate to Severe Non-segmental VitiligoPhase 2 · Recruiting · 80 people · main data estimated Dec 2027 · NCT07889492

For Pro members: 32 filings.

Cash runway Jun 30 balance sheet

About 4 quarters

$10.3M in cash and short-term investments, at its spending over the last year

What it means: how long the cash would last at the same pace, before any new money. It has raised money since that balance sheet, which is not counted here.

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

  • Shelf registration (S-3, filed Jul 25, 2025)
  • At-the-market share sales program (424B5, filed Dec 12, 2025)

For Pro members: 4 raises and their amounts, and the share count against a year ago.

Insiders

CEO Pardeep Nijhawan bought 1,000 shares on Mar 10. 6 more insider trades this year.

From Form 4: open-market buys and sales only.

For Pro members: every trade, and Pardeep Nijhawan’s 38 filings and quotes.

Get an alert when EDSA files news on its trialSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

10 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 168 dates, ranked →

EDSA's latest filings

41 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why EDSA isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. EDSA is worth about $25M and trades about 45,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.

Straight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

The price on this page is delayed at least 15 minutes.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.